nevirapine has been researched along with Acute Lymphoid Leukemia in 3 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radi, M | 1 |
| Maga, G | 1 |
| Alongi, M | 1 |
| Angeli, L | 1 |
| Samuele, A | 1 |
| Zanoli, S | 1 |
| Bellucci, L | 1 |
| Tafi, A | 1 |
| Casaluce, G | 1 |
| Giorgi, G | 1 |
| Armand-Ugon, M | 1 |
| Gonzalez, E | 1 |
| Esté, JA | 1 |
| Baltzinger, M | 1 |
| Bec, G | 1 |
| Dumas, P | 1 |
| Ennifar, E | 1 |
| Botta, M | 1 |
| Yan, ZH | 1 |
| Wu, HQ | 1 |
| Chen, WX | 1 |
| Wu, Y | 1 |
| Piao, HR | 1 |
| He, QQ | 1 |
| Chen, FE | 1 |
| De Clercq, E | 2 |
| Pannecouque, C | 2 |
| Sang, Y | 1 |
| Han, S | 1 |
| Zhuang, C | 1 |
| Chen, F | 1 |
3 other studies available for nevirapine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.
Topics: Cell Line, Tumor; Computer Simulation; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptas | 2009 |
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; | 2014 |
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Apoptosis; Drug Design; Female; HIV Infections; HIV- | 2019 |